Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years.
about
Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and RecommendationsCost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD
P2860
Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Economic evaluation of aclidin ...... OPD: an analysis over 5 years.
@en
Economic evaluation of aclidin ...... OPD: an analysis over 5 years.
@nl
type
label
Economic evaluation of aclidin ...... OPD: an analysis over 5 years.
@en
Economic evaluation of aclidin ...... OPD: an analysis over 5 years.
@nl
prefLabel
Economic evaluation of aclidin ...... OPD: an analysis over 5 years.
@en
Economic evaluation of aclidin ...... OPD: an analysis over 5 years.
@nl
P2093
P2860
P356
P1476
Economic evaluation of aclidin ...... OPD: an analysis over 5 years.
@en
P2093
Andreas Karabis
Gert Bergman
Indra Eijgelshoven
Michelle Mocarski
P2860
P304
P356
10.2147/CEOR.S57904
P407
P577
2014-04-05T00:00:00Z